APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anaesthetic Drugs and Pain Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anaesthetic Drugs and Pain Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025189 pages

Choose your research edition.

Industry ResearchAnaesthetic Drugs and Pain Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Anaesthetic Drugs and Pain Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Anaesthetic Drugs and Pain Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anaesthetic Drugs and Pain Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Anaesthetic Drugs and Pain Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anaesthetic Drugs and Pain Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anaesthetic Drugs and Pain Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anaesthetic Drugs and Pain Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anaesthetic Drugs and Pain Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anaesthetic Drugs and Pain Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anaesthetic Drugs and Pain Drugs include Johnson & Johnson, Novartis, Merck, Pfizer, Bayer AG, Baxter, Purdue Pharma, Endo International and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anaesthetic Drugs and Pain Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anaesthetic Drugs and Pain Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anaesthetic Drugs and Pain Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anaesthetic Drugs and Pain Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anaesthetic Drugs and Pain Drugs Segment by Company

Johnson & Johnson

Novartis

Merck

Pfizer

Bayer AG

Baxter

Purdue Pharma

Endo International

AstraZeneca

Anaesthetic Drugs and Pain Drugs Segment by Type

Anaesthetic Drugs

Pain Drugs

Anaesthetic Drugs and Pain Drugs Segment by Application

Hospital

Clinic

Anaesthetic Drugs and Pain Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anaesthetic Drugs and Pain Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anaesthetic Drugs and Pain Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anaesthetic Drugs and Pain Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anaesthetic Drugs and Pain Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anaesthetic Drugs and Pain Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anaesthetic Drugs and Pain Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anaesthetic Drugs and Pain Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anaesthetic Drugs and Pain Drugs Industry Trends Table 2. Anaesthetic Drugs and Pain Drugs Industry Drivers Table 3. Anaesthetic Drugs and Pain Drugs Industry Opportunities and Challenges Table 4. Anaesthetic Drugs and Pain Drugs Industry Restraints Table 5. Global Anaesthetic Drugs and Pain Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anaesthetic Drugs and Pain Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Manufacturers Table 9. Global Anaesthetic Drugs and Pain Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anaesthetic Drugs and Pain Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anaesthetic Drugs and Pain Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anaesthetic Drugs and Pain Drugs Manufacturers, Product Type & Application Table 13. Global Anaesthetic Drugs and Pain Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anaesthetic Drugs and Pain Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anaesthetic Drugs Table 17. Major Manufacturers of Pain Drugs Table 18. Global Anaesthetic Drugs and Pain Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Anaesthetic Drugs and Pain Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Anaesthetic Drugs and Pain Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2021-2026) Table 22. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2027-2032) Table 23. Global Anaesthetic Drugs and Pain Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Anaesthetic Drugs and Pain Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Anaesthetic Drugs and Pain Drugs Sales by Application (2021-2026) & (K Units) Table 32. Global Anaesthetic Drugs and Pain Drugs Sales by Application (2027-2032) & (K Units) Table 33. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2021-2026) Table 34. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2027-2032) Table 35. Global Anaesthetic Drugs and Pain Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2021-2026) & (K Units) Table 37. Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2027-2032) & (K Units) Table 38. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application (2021-2026) Table 39. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application (2027-2032) Table 40. Global Anaesthetic Drugs and Pain Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Anaesthetic Drugs and Pain Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Region (2021-2026) Table 43. Global Anaesthetic Drugs and Pain Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Anaesthetic Drugs and Pain Drugs Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2026) & (K Units) Table 47. North America Anaesthetic Drugs and Pain Drugs Sales by Country (2027-2032) & (K Units) Table 48. Europe Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2026) & (K Units) Table 50. Europe Anaesthetic Drugs and Pain Drugs Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Country (2027-2032) & (K Units) Table 57. Global Anaesthetic Drugs and Pain Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anaesthetic Drugs and Pain Drugs Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Anaesthetic Drugs and Pain Drugs Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region (2021-2026) Table 61. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region (2027-2032) Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Johnson & Johnson Anaesthetic Drugs and Pain Drugs Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis Anaesthetic Drugs and Pain Drugs Product Portfolio Table 71. Novartis Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Anaesthetic Drugs and Pain Drugs Product Portfolio Table 76. Merck Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Anaesthetic Drugs and Pain Drugs Product Portfolio Table 81. Pfizer Recent Development Table 82. Bayer AG Company Information Table 83. Bayer AG Business Overview Table 84. Bayer AG Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Bayer AG Anaesthetic Drugs and Pain Drugs Product Portfolio Table 86. Bayer AG Recent Development Table 87. Baxter Company Information Table 88. Baxter Business Overview Table 89. Baxter Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Baxter Anaesthetic Drugs and Pain Drugs Product Portfolio Table 91. Baxter Recent Development Table 92. Purdue Pharma Company Information Table 93. Purdue Pharma Business Overview Table 94. Purdue Pharma Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Purdue Pharma Anaesthetic Drugs and Pain Drugs Product Portfolio Table 96. Purdue Pharma Recent Development Table 97. Endo International Company Information Table 98. Endo International Business Overview Table 99. Endo International Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Endo International Anaesthetic Drugs and Pain Drugs Product Portfolio Table 101. Endo International Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Anaesthetic Drugs and Pain Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. AstraZeneca Anaesthetic Drugs and Pain Drugs Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Anaesthetic Drugs and Pain Drugs Distributors List Table 110. Anaesthetic Drugs and Pain Drugs Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Anaesthetic Drugs and Pain Drugs Product Image Figure 2. Global Anaesthetic Drugs and Pain Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anaesthetic Drugs and Pain Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anaesthetic Drugs and Pain Drugs Sales (2021-2032) & (K Units) Figure 5. Global Anaesthetic Drugs and Pain Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anaesthetic Drugs and Pain Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anaesthetic Drugs Image Figure 9. Pain Drugs Image Figure 10. Global Anaesthetic Drugs and Pain Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Anaesthetic Drugs and Pain Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Anaesthetic Drugs and Pain Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Anaesthetic Drugs and Pain Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2021-2032) Figure 21. Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2021-2032) Figure 26. U.S. Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2021-2032) Figure 31. Germany Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2021-2032) Figure 38. China Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2021-2032) Figure 46. Brazil Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Anaesthetic Drugs and Pain Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Anaesthetic Drugs and Pain Drugs Revenue (2021-2032) & (US$ Million) Figure 57. North America Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Anaesthetic Drugs and Pain Drugs Revenue (2021-2032) & (US$ Million) Figure 59. Europe Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Anaesthetic Drugs and Pain Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Anaesthetic Drugs and Pain Drugs Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Anaesthetic Drugs and Pain Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Anaesthetic Drugs
  • Pain Drugs
Applications
  • Hospital
  • Clinic
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • Bayer AG
  • Baxter
  • Purdue Pharma
  • Endo International
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anaesthetic Drugs and Pain Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anaesthetic Drugs and Pain Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anaesthetic Drugs and Pain Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anaesthetic Drugs and Pain Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anaesthetic Drugs and Pain Drugs Market Dynamics
  1. 2.1 Anaesthetic Drugs and Pain Drugs Industry Trends
  2. 2.2 Anaesthetic Drugs and Pain Drugs Industry Drivers
  3. 2.3 Anaesthetic Drugs and Pain Drugs Industry Opportunities and Challenges
  4. 2.4 Anaesthetic Drugs and Pain Drugs Industry Restraints
3 Anaesthetic Drugs and Pain Drugs Market by Manufacturers
  1. 3.1 Global Anaesthetic Drugs and Pain Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anaesthetic Drugs and Pain Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anaesthetic Drugs and Pain Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anaesthetic Drugs and Pain Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anaesthetic Drugs and Pain Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anaesthetic Drugs and Pain Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Anaesthetic Drugs and Pain Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anaesthetic Drugs and Pain Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anaesthetic Drugs and Pain Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anaesthetic Drugs and Pain Drugs Tier 1, Tier 2, and Tier 3
4 Anaesthetic Drugs and Pain Drugs Market by Type
  1. 4.1 Anaesthetic Drugs and Pain Drugs Type Introduction
  2. 4.1.1 Anaesthetic Drugs
  3. 4.1.2 Pain Drugs
  4. 4.2 Global Anaesthetic Drugs and Pain Drugs Sales by Type
  5. 4.2.1 Global Anaesthetic Drugs and Pain Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anaesthetic Drugs and Pain Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anaesthetic Drugs and Pain Drugs Revenue by Type
  9. 4.3.1 Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type (2021-2032)
5 Anaesthetic Drugs and Pain Drugs Market by Application
  1. 5.1 Anaesthetic Drugs and Pain Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Anaesthetic Drugs and Pain Drugs Sales by Application
  5. 5.2.1 Global Anaesthetic Drugs and Pain Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anaesthetic Drugs and Pain Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Anaesthetic Drugs and Pain Drugs Revenue by Application
  9. 5.3.1 Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application (2021-2032)
6 Global Anaesthetic Drugs and Pain Drugs Sales by Region
  1. 6.1 Global Anaesthetic Drugs and Pain Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anaesthetic Drugs and Pain Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anaesthetic Drugs and Pain Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Anaesthetic Drugs and Pain Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anaesthetic Drugs and Pain Drugs Revenue by Region
  1. 7.1 Global Anaesthetic Drugs and Pain Drugs Revenue by Region
  2. 7.1.1 Global Anaesthetic Drugs and Pain Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anaesthetic Drugs and Pain Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Anaesthetic Drugs and Pain Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anaesthetic Drugs and Pain Drugs Revenue (2021-2032)
  8. 7.2.2 North America Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anaesthetic Drugs and Pain Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anaesthetic Drugs and Pain Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Anaesthetic Drugs and Pain Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Anaesthetic Drugs and Pain Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Anaesthetic Drugs and Pain Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Anaesthetic Drugs and Pain Drugs Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Anaesthetic Drugs and Pain Drugs Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Anaesthetic Drugs and Pain Drugs Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Anaesthetic Drugs and Pain Drugs Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Endo International
  44. 8.8.1 Endo International Company Information
  45. 8.8.2 Endo International Business Overview
  46. 8.8.3 Endo International Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Endo International Anaesthetic Drugs and Pain Drugs Product Portfolio
  48. 8.8.5 Endo International Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Anaesthetic Drugs and Pain Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Anaesthetic Drugs and Pain Drugs Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anaesthetic Drugs and Pain Drugs Value Chain Analysis
  2. 9.1.1 Anaesthetic Drugs and Pain Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anaesthetic Drugs and Pain Drugs Production Mode & Process
  6. 9.2 Anaesthetic Drugs and Pain Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anaesthetic Drugs and Pain Drugs Distributors
  9. 9.2.3 Anaesthetic Drugs and Pain Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst